Clinical Trial Update: Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma (SAFARI 2) [NA]

View source ↗

Summary

The SAFARI 2 trial evaluating a novel interposition supraciliary implant for open-angle glaucoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle

Snippet

Sponsor: Ciliatech | Conditions: Glaucoma, Open-Angle | NA | Status: TERMINATED